ARCHIVES

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

Overwhelming 89 To 7 Vote By Senate Overturns President Reagan’s Veto Of NIH Reauthorization

November 29, 1985

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

ASCO, NCCN Develop Quality Measures For Cancer Care

August 25, 2006

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Bristol-Myers, Karolinska In Collaboration For Studies.

March 31, 2000

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

February 3, 1984